Nomocan
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
310 E 67th St Ste 1-45, New York City, N...Phone Number
(917) 966-8610Website
www.nomocan.comRevenue
<$5 MillionIndustry
About Nomocan
Nomocan Org Chart
Is Nomocan your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Nomocan has new funding data
Nomocan, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Nomocan is spiking on competitors!
Check if Nomocan has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Nomocan
Click to see if Nomocan had a recent Job posting/layoffs
Product Launch: Get notified when Nomocan launches new products
Earning: See what the market has to say on Nomocan recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Nomocan
Compare insights from companies similar to Nomocan, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nomocan is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nomocan is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nomocan.
Nomocan Tech Stack
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nomocan
NomoCan is pioneering a revolutionary oncology platform that integrates high-specificity diagnostics with first-in-class therapeutics, targeting core cancer-driving pathways across various tumor types. Their novel biologics are designed to bind exclusively to specific conformational epitopes on cancer cells, offering superior efficacy and safety. T... Read More